Corrigendum to "pH-Sensitive Tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease" [Eur. J. Pharm. Biopharm. 204 (2024) 114461].

IF 4.4 2区医学 Q1 PHARMACOLOGY & PHARMACY

European Journal of Pharmaceutics and Biopharmaceutics Pub Date : 2025-01-01 Epub Date: 2024-11-06 DOI:10.1016/j.ejpb.2024.114573

Sidra Altaf, Mahira Zeeshan, Hussain Ali, Ahmed Zeb, Iqra Afzal, Ayesha Imran, Danish Mazhar, Salman Khan, Fawad Ali Shah

引用次数: 0

查看原文本刊更多论文

对 "用于治疗炎症性肠病的 pH 值敏感的他克莫司负载纳米结构脂质载体"[Eur. J. Pharm. Biopharm. 204 (2024) 114461]的更正。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Pharmaceutics and Biopharmaceutics 医学-药学

CiteScore

8.80

自引率

4.10%

发文量

211

审稿时长

36 days

期刊介绍： The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics. Topics covered include for example: Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids) Aspects of manufacturing process design Biomedical aspects of drug product design Strategies and formulations for controlled drug transport across biological barriers Physicochemical aspects of drug product development Novel excipients for drug product design Drug delivery and controlled release systems for systemic and local applications Nanomaterials for therapeutic and diagnostic purposes Advanced therapy medicinal products Medical devices supporting a distinct pharmacological effect.